"This expansion into Northwest Ohio is a great achievement for our Institute, but the best part is how it will benefit the communities of the region," said Gerold Bepler, M.D., Ph.D., president and CEO of Karmanos Cancer Institute. "We are very proud of our history and roots in Detroit and the care our team provides here. We're now grateful for the opportunity to grow those service into another state."
Announced nearly a year ago, the facility's offerings extend to infusion and laboratory services, diagnostic imaging and an on-site pharmacy.
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
First earning an NCI designation in the 1970s, Karmanos has maintained its status over the decades — now one of just 51 such designated cancer programs throughout the country. The industry-leading recognition, NCI designations are earned by centers that have demonstrated scientific leadership through laboratory and clinical research, while also providing for its community. These centers are defined by their level of patient experience, scientific excellence and integration of the latest research with the aim on curing cancer and reducing its morbidity and mortality levels.
About the Barbara Ann Karmanos Cancer Institute
Karmanos Cancer Institute is a leader in transformative cancer care, research and education. The Karmanos vision is a world free of cancer. Headquartered in Detroit, Karmanos has 16 network sites and delivers world-renowned care and access to clinical trials throughout Michigan and northern Ohio. The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation.
SOURCE Karmanos Cancer Institute
Back to HCB News
